18 May 2013
Keywords: valcyte, effective, ganciclovir, cmv, swiss, drug, major
Article | 14 May 2007
Swiss drug major Roche says that the results of a trial of its oral antiviral Valcyte (valganciclovir), designed to treat ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
14 May 2007
21 May 2007
17 May 2013
© 2013 thepharmaletter.com